Colgate-Palmolive CEO reports small tax-related share withholding

Colgate-Palmolive Company Chairman, President & CEO and director reported a routine tax-related share withholding.

Rhea-AI Filing Summary

Colgate-Palmolive Company Chairman, President & CEO and director reported a routine tax-related share withholding. On 12/03/2025, the executive disposed of 1,307 shares of common stock at $78.2 per share, coded as an "F" transaction, meaning shares were withheld to cover Medicare and income tax owed on previously granted restricted stock units. The executive continues to hold those restricted stock units, reduced only by the shares used for required tax withholding.

After this transaction, the executive beneficially owns 338,756 shares directly. Additional indirect holdings include 53,923 shares through the issuer's 401(k) plan trustee, 52,000 shares through a spouse trust, and 335 shares through another trust.

Insider Trade Summary

Exercise Price or Tax Liability: 1,307 shares

Exercise Price or Tax Liability 4 txns

Insider Wallace Noel R.

Role Chairman, President & CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,307	$78.20	$102K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 338,756 shares (Direct); Common Stock — 53,923 shares (Indirect, By Issuer's 401(k) Plan Trustee); Common Stock — 52,000 shares (Indirect, By Spouse Trust); Common Stock — 335 shares (Indirect, By Trust)

Footnotes (1)

1. F1. Payment of Medicare and income tax liability by withholding shares of stock from restricted stock units previously granted under the issuer's incentive compensation plan. The reporting person continues to hold the restricted stock units originally granted, less the amount of this required tax withholding.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Colgate-Palmolive (CL) report in this Form 4?

The filing shows the Chairman, President & CEO disposed of 1,307 shares of common stock on 12/03/2025, coded as an "F" tax-withholding transaction at $78.2 per share.

Why were Colgate-Palmolive (CL) shares withheld from the executive?

Shares were withheld to pay Medicare and income tax liabilities arising from restricted stock units granted under the issuer's incentive compensation plan.

Does the Colgate-Palmolive (CL) executive still hold the restricted stock units?

Yes. The filing states the reporting person continues to hold the original restricted stock units, reduced only by the units used for the required tax withholding.

How many Colgate-Palmolive (CL) shares does the executive own directly after the transaction?

Following the reported transaction, the executive directly owns 338,756 shares of Colgate-Palmolive common stock.

What are the executive's indirect holdings of Colgate-Palmolive (CL) stock?

Indirect holdings include 53,923 shares through the issuer's 401(k) plan trustee, 52,000 shares via a spouse trust, and 335 shares through another trust.

What is the role of the reporting person at Colgate-Palmolive (CL)?

The reporting person serves as a Director and as Chairman, President & CEO of Colgate-Palmolive Company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/05/2025 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wallace Noel R.

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/03/2025		F(1)		1,307	D	$78.2	338,756	D
Common Stock								53,923	I	By Issuer's 401(k) Plan Trustee
Common Stock								52,000	I	By Spouse Trust
Common Stock								335	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Payment of Medicare and income tax liability by withholding shares of stock from restricted stock units previously granted under the issuer's incentive compensation plan. The reporting person continues to hold the restricted stock units originally granted, less the amount of this required tax withholding.

	/s/ Kristine Hutchinson, Attorney-in-Fact	12/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.